Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Mentari Therapeutics Files Post-Merger Financials for Q3 2026

Mentari Therapeutics, Inc. filed a Form 8-K on November 16, 2026, submitting unaudited condensed consolidated financial statements and Management's Discussion and Analysis for the three and nine months ended September 30, 2026, following its merger closing on November 6, 2026.

Aditi Sarkar | 16 November 2026

Timothy White Joins AirJoule Board, Ajay Agrawal Exits

AirJoule Technologies Corporation filed a Form 8-K on November 16, 2026, disclosing a director appointment and resignation effective November 12, 2026, as well as the release of its third-quarter 2026 financial and operational results.

Vinay Lochav | 16 November 2026

Xtant Medical Reports Q3 2026 Financial Results

Xtant Medical Holdings, Inc. filed a Form 8-K with the SEC on November 16, 2026, announcing its financial results for the third quarter of 2026 via a press release furnished as Exhibit 99.1.

Vinay Lochav | 16 November 2026

CBL International Replaces Auditor MRI with Privatco CPA

CBL International Limited filed a current report with the SEC on November 16, 2026, disclosing the appointment of Privatco CPA Limited as its independent registered public accounting firm and the simultaneous dismissal of MRI Moores Rowland LLP, both effective November 13, 2026.

Anjali Anand | 16 November 2026

InspireMD Prices $37.5M Offering With Pre-Funded Warrants

InspireMD, Inc. filed a Form 8-K on November 16, 2026, disclosing an underwriting agreement dated November 13, 2026, for an underwritten public offering expected to raise approximately $37.5 million in gross proceeds.

Vinay Lochav | 16 November 2026

Huadi EGM Approves 8-to-1 Share Consolidation for Nov. 26

Huadi International Group Co., Ltd. filed a Form 6-K on November 16, 2026, reporting the results of an extraordinary general meeting of shareholders held that same day, at which shareholders approved a share consolidation, a par value reduction, and an authorized share capital increase.

Vinay Lochav | 16 November 2026

Golden Sun Technology Elects Nasdaq Home Country Exemptions

Golden Sun Technology Group Limited filed a Form 6-K on November 16, 2026, disclosing its election to rely on certain home country corporate governance exemptions available to foreign private issuers under Nasdaq Listing Rule 5615.

Aditi Sarkar | 16 November 2026

Klygefa Wins FDA Approval for Myasthenia Gravis

AstraZeneca PLC filed a Form 6-K on 16 November 2026 disclosing that the US Food and Drug Administration approved Klygefa (gefurulimab) for the treatment of generalised myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive.

Vinay Lochav | 16 November 2026

Evogene Chairman Nir Nimrodi Resigns from Board

Evogene Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 16, 2026, disclosing the resignation of Nir Nimrodi as chairman and member of the board of directors, effective November 13, 2026.

Aditi Sarkar | 16 November 2026

Nixxy Posts $3.9M Nine-Month Loss Through September 2026

Nixxy, Inc. filed its Form 10-Q with the SEC on November 16, 2026, covering the quarterly period ended September 30, 2026, reporting condensed consolidated financial results for the three and nine months ended on that date.

Manish Choudhary | 16 November 2026
Support

Hi! How can we help you today?

Loading…